Homma S, Di Tullio M R, Sacco R L, Mihalatos D, Li Mandri G, Mohr J P
Department of Medicine, Columbia-Presbyterian Medical Center, New York, NY 10032.
Stroke. 1994 Mar;25(3):582-6. doi: 10.1161/01.str.25.3.582.
Patent foramen ovale is associated with ischemic stroke in patients without a clearly identifiable etiology for stroke (cryptogenic stroke). Paradoxical embolization is thought to be a potential mechanism. However, patent foramen ovale is also found in patients with known cause of stroke. Therefore, using contrast transesophageal echocardiography, we characterized the patent foramen ovale in cryptogenic stroke patients to assess morphological factors that may contribute to paradoxical embolization.
Contrast transesophageal echocardiographic studies of 74 consecutive patients referred for ischemic stroke were reviewed. Twenty-three patients with patent foramen ovale were identified. These patients were classified as having strokes of determined origin or cryptogenic strokes according to criteria developed for the Stroke Data Bank of the National Institute of Neurological Disorders and Stroke. Separation of septum primum from secundum and the number of microbubbles appearing in left atrium were then quantitated. These parameters were compared between patients with cryptogenic stroke and those with known cause of stroke.
The patent foramen ovale dimension was significantly larger in patients with cryptogenic stroke compared with patients with an identifiable cause of stroke (2.1 +/- 1.7 mm versus 0.57 +/- 0.78 mm [mean +/- SD]; P < .01). The number of microbubbles was also greater in patients with cryptogenic stroke compared with patients with an identifiable cause of stroke (13.9 +/- 10.7 versus 1.6 +/- 0.8 [mean +/- SD]; P < .0005).
Patients with cryptogenic stroke have larger patent foramen ovale with more extensive right-to-left interatrial shunting than patients with stroke of determined cause. Transesophageal echocardiographically identifiable characteristics of patent foramen ovale may be important in defining the clinical significance of individual patent foramina.
卵圆孔未闭与无明确可识别病因的缺血性卒中(隐源性卒中)患者相关。反常栓塞被认为是一种潜在机制。然而,在已知卒中病因的患者中也发现有卵圆孔未闭。因此,我们采用对比经食管超声心动图对隐源性卒中患者的卵圆孔未闭进行特征分析,以评估可能导致反常栓塞的形态学因素。
回顾了74例因缺血性卒中而接受检查的连续患者的对比经食管超声心动图研究资料。确定有23例患者存在卵圆孔未闭。根据美国国立神经疾病和卒中研究所卒中数据库制定的标准,将这些患者分为明确病因性卒中和隐源性卒中。然后对原发隔与继发隔的分离情况以及左心房中出现的微泡数量进行定量分析。对隐源性卒中患者和已知病因性卒中患者的这些参数进行比较。
与有明确病因的卒中患者相比,隐源性卒中患者的卵圆孔未闭尺寸明显更大(2.1±1.7mm对0.57±0.78mm[平均值±标准差];P<.01)。与有明确病因的卒中患者相比,隐源性卒中患者的微泡数量也更多(13.9±10.7对1.6±0.8[平均值±标准差];P<.0005)。
与有明确病因的卒中患者相比,隐源性卒中患者的卵圆孔未闭更大,且存在更广泛的右向左心房分流。经食管超声心动图可识别的卵圆孔未闭特征可能对确定个体卵圆孔未闭的临床意义很重要。